Recs

1

DaVita Shares Plunged: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of dialysis-services provider DaVita (NYSE: DVA  ) were reeling today, falling as much as 14% in intraday trading after getting slapped with a Wall Street downgrade.

So what: An analyst at Citigroup (NYSE: C  ) put a thumbs-down on DaVita today, dropping his rating from buy to hold. The primary concerns in the downgrade were the stock's valuation -- prior to today's drop it traded at 18 times trailing earnings -- and the company's exposure to legal problems with the government. Take the two together, and there's a case to be made for backing away from a bullish stance.

Now what: If Wall Street analysts were always the last word in what investors should do, investing would be a lot less confusing. We'd simply follow their recommendations and get on with more important things in our lives, like watching YouTube videos.

Unfortunately, it's not that simple since Wall Street analysts don't always get it right. DaVita bulls would be wise to take note of Citigroup's concerns and figure out whether they really are reason to throttle down the optimism, but knee-jerk selling is probably a bad idea.

Want to keep up to date on DaVita? Add it to your watchlist.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

The Motley Fool owns shares of Citigroup. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Fool contributor Matt Koppenheffer does not have a financial interest in any of the companies mentioned. You can check out what Matt is keeping an eye on by visiting his CAPS portfolio, or you can follow Matt on Twitter @KoppTheFool or Facebook. The Fool’s disclosure policy prefers dividends over a sharp stick in the eye.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1561912, ~/Articles/ArticleHandler.aspx, 5/26/2012 4:46:43 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 19 hours ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:00 PM
DVA $81.76 Down -0.26 -0.32%
DaVita, Inc. CAPS Rating: ***
C $26.47 Down -0.19 -0.71%
Citigroup Inc CAPS Rating: ***

Advertisement